Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-05 5:17 pm Sale | 2024-11-04 | 13G | Aileron Therapeutics, Inc. ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 960,665 4.400% | -851,962 (-47.00%) | Filing History |
| 2024-03-05 7:14 pm Purchase | 2024-02-28 | 13G | Aileron Therapeutics, Inc. ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,812,627 6.200% | 1,812,627 (New Position) | Filing History |
| 2024-02-14 10:28 am Purchase | 2023-12-31 | 13G | Silver Point Specialty Lending Fund | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 5,004,910 13.600% | 5,004,910 (New Position) | Filing |
| 2021-09-23 6:56 pm Sale | 2021-09-22 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,156,255 3.010% | -1,022,745 (-46.94%) | Filing History |
| 2021-02-16 1:35 pm Purchase | 2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 2,179,000 (New Position) | Filing History |
| 2021-02-03 6:14 pm Purchase | 2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 2,179,000 (New Position) | Filing History |